title: Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780.
abstract: Alzheimer's disease is the most prevalent cause of dementia and is associated with accumulation of amyloid-β peptide (Aβ), particularly the 42-amino acid Aβ1-42, in the brain. Aβ1-42 levels can be decreased by γ-secretase modulators (GSM), which are small molecules that modulate γ-secretase, an enzyme essential for Aβ production. BMS-869780 is a potent GSM that decreased Aβ1-42 and Aβ1-40 and increased Aβ1-37 and Aβ1-38, without inhibiting overall levels of Aβ peptides or other APP processing intermediates. BMS-869780 also did not inhibit Notch processing by γ-secretase and lowered brain Aβ1-42 without evidence of Notch-related side effects in rats. Human pharmacokinetic (PK) parameters were predicted through allometric scaling of PK in rat, dog, and monkey and were combined with the rat pharmacodynamic (PD) parameters to predict the relationship between BMS-869780 dose, exposure and Aβ1-42 levels in human. Off-target and safety margins were then based on comparisons to the predicted exposure required for robust Aβ1-42 lowering. Because of insufficient safety predictions and the relatively high predicted human daily dose of 700 mg, further evaluation of BMS-869780 as a potential clinical candidate was discontinued. Nevertheless, BMS-869780 demonstrates the potential of the GSM approach for robust lowering of brain Aβ1-42 without Notch-related side effects.
authors.affiliation: Exploratory Biology and Genomics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Jeremy H
authors.initials: JH
authors.lastname: Toyn
authors.affiliation: Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Lorin A
authors.initials: LA
authors.lastname: Thompson
authors.affiliation: Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Kimberley A
authors.initials: KA
authors.lastname: Lentz
authors.affiliation: Exploratory Biology and Genomics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Jere E
authors.initials: JE
authors.lastname: Meredith
authors.affiliation: Exploratory Biology and Genomics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Catherine R
authors.initials: CR
authors.lastname: Burton
authors.affiliation: Exploratory Biology and Genomics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Sethu
authors.initials: S
authors.lastname: Sankaranararyanan
authors.affiliation: Exploratory Biology and Genomics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Valerie
authors.initials: V
authors.lastname: Guss
authors.affiliation: Exploratory Biology and Genomics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA ; Preclinical Sciences, Alexion Pharmaceuticals, Inc 352 Knotter Drive, Cheshire, CT 06410, USA.
authors.forename: Tracey
authors.initials: T
authors.lastname: Hall
authors.affiliation: Exploratory Biology and Genomics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Lawrence G
authors.initials: LG
authors.lastname: Iben
authors.affiliation: Exploratory Biology and Genomics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Carol M
authors.initials: CM
authors.lastname: Krause
authors.affiliation: Exploratory Biology and Genomics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Rudy
authors.initials: R
authors.lastname: Krause
authors.affiliation: Exploratory Biology and Genomics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Xu-Alan
authors.initials: XA
authors.lastname: Lin
authors.affiliation: Exploratory Biology and Genomics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Maria
authors.initials: M
authors.lastname: Pierdomenico
authors.affiliation: Exploratory Biology and Genomics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Craig
authors.initials: C
authors.lastname: Polson
authors.affiliation: Exploratory Biology and Genomics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Alan S
authors.initials: AS
authors.lastname: Robertson
authors.affiliation: Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: R Rex
authors.initials: RR
authors.lastname: Denton
authors.affiliation: Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: James E
authors.initials: JE
authors.lastname: Grace
authors.affiliation: Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: John
authors.initials: J
authors.lastname: Morrison
authors.affiliation: Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Joseph
authors.initials: J
authors.lastname: Raybon
authors.affiliation: Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Xiaoliang
authors.initials: X
authors.lastname: Zhuo
authors.affiliation: Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Kimberly
authors.initials: K
authors.lastname: Snow
authors.affiliation: Lead Discovery and Lead Profiling, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Ramesh
authors.initials: R
authors.lastname: Padmanabha
authors.affiliation: Lead Discovery and Lead Profiling, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA ; High Throughput Biology, Boehringer Ingelheim, 900 Ridgebury Road, Ridgefield, CT 06877, USA.
authors.forename: Michele
authors.initials: M
authors.lastname: Agler
authors.affiliation: Lead Discovery and Lead Profiling, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Kim
authors.initials: K
authors.lastname: Esposito
authors.affiliation: Lead Discovery and Lead Profiling, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: David
authors.initials: D
authors.lastname: Harden
authors.affiliation: Lead Discovery and Lead Profiling, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Margaret
authors.initials: M
authors.lastname: Prack
authors.affiliation: Lead Discovery and Lead Profiling, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA ; Stratford High School, 45 North Parade, Stratford, CT 06615, USA.
authors.forename: Sam
authors.initials: S
authors.lastname: Varma
authors.affiliation: Lead Discovery and Lead Profiling, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA ; External Research Solutions, WWMC, Pfizer World Wide Research & Development, Eastern Point Road, Groton, CT 06340, USA.
authors.forename: Victoria
authors.initials: V
authors.lastname: Wong
authors.affiliation: Lead Discovery and Lead Profiling, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA ; Arvinas Inc, 5 Science Park, New Haven, CT 06511, USA.
authors.forename: Yingjie
authors.initials: Y
authors.lastname: Zhu
authors.affiliation: Lead Discovery and Lead Profiling, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Tatyana
authors.initials: T
authors.lastname: Zvyaga
authors.affiliation: Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Samuel
authors.initials: S
authors.lastname: Gerritz
authors.affiliation: Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Lawrence R
authors.initials: LR
authors.lastname: Marcin
authors.affiliation: Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Mendi A
authors.initials: MA
authors.lastname: Higgins
authors.affiliation: Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Jianliang
authors.initials: J
authors.lastname: Shi
authors.affiliation: Discovery Analytical Sciences, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA ; Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer World Wide Research & Development, Eastern Point Road, Groton, CT 06340, USA.
authors.forename: Cong
authors.initials: C
authors.lastname: Wei
authors.affiliation: Discovery Analytical Sciences, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Joseph L
authors.initials: JL
authors.lastname: Cantone
authors.affiliation: Discovery Analytical Sciences, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Dieter M
authors.initials: DM
authors.lastname: Drexler
authors.affiliation: Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: John E
authors.initials: JE
authors.lastname: Macor
authors.affiliation: Discovery Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Richard E
authors.initials: RE
authors.lastname: Olson
authors.affiliation: Exploratory Biology and Genomics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Michael K
authors.initials: MK
authors.lastname: Ahlijanian
authors.affiliation: Exploratory Biology and Genomics, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, USA.
authors.forename: Charles F
authors.initials: CF
authors.lastname: Albright
references.citation: J Mol Biol. 2009 Jan 16;385(2):642-52
references.pmid: 19013469
references.citation: J Neurosci. 2009 Oct 14;29(41):13042-52
references.pmid: 19828817
references.citation: Neurodegener Dis. 2011;8(6):455-64
references.pmid: 21389687
references.citation: Curr Opin Pharmacol. 2007 Feb;7(1):112-8
references.pmid: 17169612
references.citation: J Biol Chem. 2003 Jul 4;278(27):24294-301
references.pmid: 12707272
references.citation: J Biol Chem. 2008 Jan 11;283(2):677-83
references.pmid: 17962197
references.citation: Nature. 1999 Apr 8;398(6727):513-7
references.pmid: 10206644
references.citation: Bioorg Med Chem Lett. 2011 Aug 15;21(16):4832-5
references.pmid: 21742495
references.citation: Int J Alzheimers Dis. 2012;2012:591392
references.pmid: 23346458
references.citation: Bioorg Med Chem Lett. 2010 Jan 15;20(2):755-8
references.pmid: 20005099
references.citation: J Biol Chem. 2004 Mar 26;279(13):12876-82
references.pmid: 14709552
references.citation: Neuron. 2010 Sep 9;67(5):769-80
references.pmid: 20826309
references.citation: Nature. 2001 Nov 8;414(6860):212-6
references.pmid: 11700559
references.citation: J Biol Chem. 2011 Jun 17;286(24):21440-9
references.pmid: 21454611
references.citation: J Neurosci. 2012 Feb 8;32(6):2037-50
references.pmid: 22323718
references.citation: Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):11872-7
references.pmid: 10518543
references.citation: Mol Pharmacol. 1999 Dec;56(6):1329-39
references.pmid: 10570062
references.citation: PLoS One. 2012;7(1):e30484
references.pmid: 22238696
references.citation: J Clin Invest. 2003 Aug;112(3):440-9
references.pmid: 12897211
references.citation: Adv Drug Deliv Rev. 2007 Sep 30;59(11):1177-92
references.pmid: 17826864
references.citation: Nature. 2013 Jan 3;493(7430):56-61
references.pmid: 23254940
references.citation: J Pharmacol Exp Ther. 2013 Mar;344(3):686-95
references.pmid: 23275065
references.citation: Bioorg Med Chem Lett. 2007 Jul 15;17(14):4006-11
references.pmid: 17502137
references.citation: EMBO J. 2004 Feb 11;23(3):483-8
references.pmid: 14749724
references.citation: Toxicol Sci. 2014 Jan;137(1):249-58
references.pmid: 24085193
references.citation: PLoS One. 2013 Dec 20;8(12):e83096
references.pmid: 24376644
references.citation: Int J Alzheimers Dis. 2012;2012:295207
references.pmid: 23365783
references.citation: J Biol Chem. 2007 Nov 23;282(47):33985-93
references.pmid: 17911105
references.citation: J Biol Chem. 2006 Mar 24;281(12):7890-8
references.pmid: 16434391
references.citation: J Biol Chem. 2008 Aug 22;283(34):22992-3003
references.pmid: 18574238
references.citation: J Neurochem. 2012 Apr;121(2):277-86
references.pmid: 22035227
references.citation: EMBO J. 2011 Oct 14;30(23):4815-24
references.pmid: 22002539
references.citation: BMC Neurosci. 2007 Jul 24;8:54
references.pmid: 17650315
references.citation: Science. 2002 Jul 19;297(5580):353-6
references.pmid: 12130773
references.citation: Mol Neurodegener. 2012 Dec 18;7:61
references.pmid: 23249765
references.citation: Proc Natl Acad Sci U S A. 2006 May 2;103(18):6889-94
references.pmid: 16636269
references.citation: J Biol Chem. 2012 Apr 6;287(15):11810-9
references.pmid: 22334705
references.citation: J Alzheimers Dis. 2011;25(1):3-28
references.pmid: 21335653
references.citation: Neuropharmacology. 2013 Jul;70:278-86
references.pmid: 23485401
references.citation: Int J Alzheimers Dis. 2012;2012:210756
references.pmid: 23320246
references.citation: J Biol Chem. 2013 Apr 5;288(14):9710-9720
references.pmid: 23396974
references.citation: Alzheimers Res Ther. 2013 Apr 18;5(2):19
references.pmid: 23597079
references.citation: J Pharmacokinet Biopharm. 1993 Aug;21(4):457-78
references.pmid: 8133465
references.citation: J Clin Pharmacol. 2014 May;54(5):528-36
references.pmid: 24343761
references.citation: J Neurochem. 2013 May;125(3):465-72
references.pmid: 23240999
references.citation: EMBO J. 2012 May 16;31(10):2261-74
references.pmid: 22505025
references.citation: ACS Med Chem Lett. 2011 Mar 29;2(6):471-6
references.pmid: 24900332
references.citation: J Neurosci. 2006 Nov 15;26(46):12081-8
references.pmid: 17108181
references.citation: EMBO J. 2002 Oct 15;21(20):5408-16
references.pmid: 12374741
references.citation: J Med Chem. 2012 Jan 12;55(1):489-502
references.pmid: 22098494
references.citation: ACS Med Chem Lett. 2011 Aug 05;2(10):786-91
references.pmid: 24900267
references.citation: J Pharmacol Exp Ther. 2005 Feb;312(2):635-43
references.pmid: 15452193
references.citation: J Biol Chem. 2011 Apr 29;286(17):15240-51
references.pmid: 21357415
references.citation: Biochem Biophys Res Commun. 2002 Dec 13;299(4):569-73
references.pmid: 12459176
references.citation: Pharmacol Ther. 2007 Nov;116(2):266-86
references.pmid: 17716740
references.citation: J Alzheimers Dis. 2012;28(4):809-22
references.pmid: 22072214
references.citation: Toxicol Sci. 2004 Nov;82(1):341-58
references.pmid: 15319485
references.citation: Anal Biochem. 1996 May 15;237(1):24-9
references.pmid: 8660532
references.citation: J Biol Chem. 2011 Oct 28;286(43):37181-6
references.pmid: 21896486
references.citation: Bioorg Med Chem Lett. 2010 Sep 15;20(18):5380-4
references.pmid: 20724152
references.citation: J Neurosci Methods. 2006 Oct 15;157(1):71-81
references.pmid: 16678274
references.citation: ACS Med Chem Lett. 2010 Mar 22;1(3):120-4
references.pmid: 24900185
references.citation: Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1683-8
references.pmid: 8643690
references.citation: J Pharmacol Exp Ther. 2008 Mar;324(3):957-69
references.pmid: 18156464
references.citation: Alzheimers Res Ther. 2014 Mar 12;6(2):14
references.pmid: 25031632
references.citation: Br J Pharmacol. 2011 May;163(2):375-89
references.pmid: 21232036
references.citation: Nat Rev Drug Discov. 2011 Aug 19;10(9):698-712
references.pmid: 21852788
references.citation: J Chem Inf Model. 2006 Sep-Oct;46(5):1919-23
references.pmid: 16995722
references.citation: Neurodegener Dis. 2011;8(1-2):15-24
references.pmid: 20689247
references.citation: Alzheimer Dis Assoc Disord. 2007 Oct-Dec;21(4):292-9
references.pmid: 18090435
references.citation: Neuron. 2003 Jul 31;39(3):409-21
references.pmid: 12895417
references.citation: BMC Neurosci. 2010 Nov 05;11:143
references.pmid: 21054826
references.citation: ACS Chem Neurosci. 2011 Dec 21;2(12):705-710
references.pmid: 22229075